| 摘要 |
Device for transdermal administration of dextromethorphan, (+)-3-methoxy-17-methyl-9a,13a,14a-morphinan, optionally encompassing salts, prodrugs and metabolites thereof, optionally together with pharmaceutically acceptable carrier(s) to a human being or an animal in order to achieve an antitussive effect. Use of an antitussive compound comprising dextromethorphan, (+)-3-methoxy-17-methyl-9a,13a,14a-morphinan, optionally encompassing salts, prodrugs and metabolites thereof, and optionally together with pharmaceutically acceptable carrier(s), for the manufacture of a composition to be administered transdermally for achieving an antitussive effect. Method for achieving an antitussive effect in a living body by transdermal administration of a compound comprising dextromethorphan, (+)-3-methoxy-17-methyl-9a,13a,14a-morphinan, optionally encompassing salts, prodrugs and metabolites thereof, and optionally together with pharmaceutically acceptable carrier(s).
|
